Artificial intelligence tools in neuro-oncology demonstrate robust performance in detecting brain metastases and predicting clinical outcomes.

Doctors report that New York City and nearby areas are seeing a sharp jump in cases of influenza this flu season, weeks sooner than expected.

New reports suggest that apps like YouTube, TikTok, and other social media platforms are a constant in daily life for teens in the US.

The CDC is changing its long-standing recommendation that all newborns receive the hepatitis B vaccination shortly after birth.

An abbreviated version of the Brain Care Score predicts risk for dementia, stroke, and late-life depression based on lifestyle factors alone.

Baseline neuropsychiatric profiles in older adults stratify future cognitive decline, neuropathology, and risk for MCI or dementia.

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

Cognitive impairment is positively associated with neuropsychiatric symptoms in both individuals with Down syndrome and older adults without Down syndrome.

The FDA has granted Fast Track designation to ST-503 for the treatment of small fiber neuropathy, a chronic neuropathic pain disorder.

Among women with fibromyalgia, overactive bladder is prevalent and may often be associated with higher symptom severity and comorbidity.

Ginkgo biloba and several other therapies offer modest cognitive benefits in vascular cognitive impairment, but heterogeneous evidence limits certainty.